The sales team of Amman Pharmaceutical Industries visited the unolab factories in Spain, as Amman manufactures some of its products in this factory within the company’s contractual manufacturing plans to ensure the availability of high-quality, reliable, safety and efficacy Jordanian and national medicines at an affordable price for the patient, and where the UNOLAB factory is distinguished Pharmaceutical factories in Europe in general, in the manufacture of new pharmaceutical forms that are not manufactured locally, and all this is in the interest of developing the national pharmaceutical industry and making maximum use of the available production capacity to achieve self-sufficiency in medicines and medical supplies.
The visit aims to learn about the latest developments and innovative mechanisms in global pharmaceutical manufacturing processes, including the manufacture of Amman Pharma products.
Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success.
